EMA Committee for Medicinal Products for Human Use (CHMP) Adopts Positive Opinion Recommending Authorization for the Use of Moderna's Omicron-Targeting Bivalent Booster in the European Union PressReach · Sep 2, 2022
Comera Life Sciences Announces Up To $15 million Purchase Agreement with Arena Business Solutions PressReach · Sep 1, 2022
CENTENE CORPORATION APPOINTS ASHLEE KNUCKEY AS CHIEF ETHICS AND COMPLIANCE OFFICER PressReach · Sep 1, 2022
Zimmer Biomet and Surgical Planning Associates Announce Exclusive Multi-Year Co-Marketing Agreement for HipInsight(TM) Mixed Reality System for Total Hip Replacement PressReach · Sep 1, 2022
Amarin to Present at H.C. Wainwright's 24th Annual Global Investment Conference PressReach · Aug 31, 2022
BioCardia Announces Positive DSMB Review and Recommendation to Continue Phase III Pivotal CardiAMP Cell Therapy Heart Failure Trial PressReach · Aug 31, 2022
Dr. David Brailer, M.D., Ph.D. Joins Cigna as Executive Vice President and Chief Health Officer PressReach · Aug 31, 2022
Illumina Deepens Commitment to Customers in China with New Manufacturing Site PressReach · Aug 31, 2022
Outlook Therapeutics® Re-Submits Biologics License Application for ONS-5010 as a Treatment for Wet AMD to the U.S. Food and Drug Administration PressReach · Aug 31, 2022
